This endothelial dysfunction translates to increased monocyte adherence and vascular inflammation, as ImP upregulates ICAM‐1, VCAM‐1, and E-selectin, and correlates clinically with elevated soluble VCAM‐1 and CRP levels in patients with CAD [23, 25]. This evidence concerns the gene VCAM1 and endothelial dysfunction.